# Injection Site Pain Comparison of Excipient Solutions

> **NCT04482725** · PHASE1 · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 108 (actual)

## Conditions studied

- Obesity

## Interventions

- **OTHER:** Trial product 1
- **OTHER:** Trial product 2
- **OTHER:** Trial product 3
- **OTHER:** Trial product 4
- **OTHER:** Trial product 5
- **OTHER:** Trial product 6
- **OTHER:** Trial product 7
- **OTHER:** Trial product 8
- **OTHER:** Trial product 9
- **OTHER:** Trial product 10
- **OTHER:** Trial product 10
- **OTHER:** Trial product 12

## Key facts

- **NCT ID:** NCT04482725
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-07-20
- **Primary completion:** 2020-09-24
- **Final completion:** 2020-09-25
- **Target enrollment:** 108 (ACTUAL)
- **Last updated:** 2021-10-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04482725

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04482725, "Injection Site Pain Comparison of Excipient Solutions". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04482725. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*